Axiom Advisory’s Johnson & Johnson JNJ Stock Holding History

Axiom Advisory’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.2M	Buy	20,096 +473	+2%	+$75.4K	0.03%	81
2024 Q2	$2.92M	Buy	+19,623	New	+$2.92M	0.03%	79

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Axiom Advisory's JNJ Position: Q3 2024 in Review

Axiom Advisory increased its Johnson & Johnson (JNJ) stake by 2.4% in Q3 2024, buying an estimated $75.4K and bringing the position to 20,096 shares worth $3.2M. The position accounts for 0.03% of the portfolio, ranked #81.

Axiom Advisory first reported a position in JNJ in Q2 2024 and has held it in 2 quarters since. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

Axiom Advisory held 20,096 shares of Johnson & Johnson worth $3.2M as of Q3 2024.
Axiom Advisory bought 473 Johnson & Johnson shares in Q3 2024, an estimated $75.4K.
Johnson & Johnson made up 0.03% of Axiom Advisory's portfolio in Q3 2024, its #81 holding.
Axiom Advisory first reported a position in Johnson & Johnson in Q2 2024 and has held it in 2 quarters since.
3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Axiom Advisory's 13F filing for Q3 2024, filed 7 Oct 2024.